Seagen to Present at the J.P. Morgan Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005153/en/

For Investors
Peggy Pinkston
Senior Vice President, Investor Relations
(425) 527-4160
[email protected]

For Media
David Caouette
Vice President, Corporate Communications
(310) 430-3476
[email protected]

Source: Seagen Inc.

You May Also Be Interested In

• Brixton Biosciences Strengthens Board with Industry Veterans as Company Advances Towards Commercialization of Reneurx™ Nerve-Selective Therapy for Pain Associated with Knee Osteoarthritis
• With AWS Hackathon Win, TASKING-Led Team Demonstrates the Future of Automotive Safety-Critical Software Development
• Former President of DePuy Synthes U.S. Joins Peptilogics Board